Document is current
Any future updates will be listed below
-
Authors
Wey, Pierre-François
Loheas, Damien
Lamblin, Antoine
Riche, Benjamin
Rabilloud, Muriel
Escarment, Jacques
Puidupin, Marc
Quintin, Luc
Martinez, Jean-Yves
Cividjian, Andrei
-
Funding
Funding for this research was provided by:
Service de Santé des Armées
FEDER Rhone Alpes
RAPID-DGA
U of Lyon
- License Information
-
More Information
Article History
Received: 10 September 2019
Accepted: 21 September 2020
First Online: 6 October 2020
Compliance with ethical standards
:
: A. Cividjian and L. Quintin hold a US patent (8 641 632, B2, Feb. 4, 2014: “<i>Data acquisition and treatment of cardiovascular signals in relationship to adequacy (“depth”) of anaesthesia”: CARDEAN</i>) and are shareholders of Alpha-2 Ltd. (start-up: <i>Jeune Entreprise Innovante</i>), Lyon, France. The other authors declare no conflicts of interest.
: The study was approved by the local (University of Lyon) and national Institutional Review Boards. The procedures used in this study adhere to the tenets of the Declaration of Helsinki. The trial was registered prior to patient enrolment (EudraCT: 2010-A00037-32; Principal investigator: JY Martinez, IRB-CPP: 2010-006 B, April 9, 2013).
: Written Informed consent was obtained from all individual participants included in the study.
